Statement from Michael and Susan Pretti
Parents of Alex Jeffrey Pretti
“We are heartbroken but also very angry.
Alex was a kindhearted soul who cared deeply for his family and friends and also the American veterans whom he cared for as an ICU nurse at the Minneapolis VA hospital. Alex wanted to make a difference in this world. Unfortunately, he will not be with us to see his impact.
I do not throw around the ‘hero’ term lightly. However, his last thought and act was to protect a woman. The sickening lies told about our son by the administration are reprehensible and disgusting. Alex is clearly not holding a gun when attacked by Trump’s murdering and cowardly ICE thugs. He had his phone in his right hand and his empty left hand is raised above his head while trying to protect the woman ICE just pushed down, all while being pepper sprayed.
Please get the truth out about our son. He was a good man. Thank you.
Kare 11 local news just read, in full, this statement from Michael and Susan Pretti, the parents of Alex Pretti.
"Please get the truth out about our son."
25.01.2026 00:43
👍 24922
🔁 12846
💬 200
📌 448
The moral panic about GLP-1 rebound
Scientists and journalists are piling on the misery about the weight regain after medication
If you stop taking blood pressure meds, your BP goes up. We call that medicine.
If you stop taking GLP-1s, your weight goes up. Scientists are calling it "weight recidivism"—a term for convicted criminals.
Why is obesity still treated as a moral failure? #GLP
open.substack.com/pub/overmatt...
09.01.2026 12:13
👍 28
🔁 10
💬 2
📌 0
While there is so much that is disturbing about this case study in the destruction of academic freedom, one high point is the refusal of the targeted professor to submit
07.01.2026 11:32
👍 164
🔁 60
💬 3
📌 3
We sent in our letter and I know Min. Joly received it. This was not part of the ask.
Investing directly in tri-council is a better use of these funds.
We already have a recruitment advantage over the US now.
We need to value what we already and invest in Canadian research sovereignty
12.12.2025 00:54
👍 20
🔁 7
💬 1
📌 0
Canadian scientist here. I don't want this. I want you to fund our excellent early career scientists who do great work in Canada. Fund them properly and that will help 1000x more than recruiting handfuls of cherry picked bigwigs from Harvard, Stanford and MIT who will leave after a few years.
11.12.2025 22:37
👍 187
🔁 48
💬 7
📌 2
Very similar to the ARB story
21.11.2025 03:40
👍 2
🔁 0
💬 0
📌 0
Yes those are the 2 options to create an indication: (1) compare to placebo when standard of care (SoC) contraindicated or (2) head2head vs SoC for OG indication. 1 "easier" & addresses a potentially bigger gap. I meant that 1 is ethically justifiable vs placebo instead of SoC, whereas 2 is not
21.11.2025 03:39
👍 1
🔁 0
💬 1
📌 0
Seeing this incl criterion ("cannot tolerate Spiro") a lot with ongoing nsMRAs/ASIs RCTs. Makes ethical sense since can't offer placebo in spiro-eligible pts, but usual problems are hyperK and dec eGFR; does any1 think these drugs will really be better tolerated? Spiro will not be usurped easily
20.11.2025 16:42
👍 1
🔁 1
💬 2
📌 0
It'd look like many cardiology drug CI/KM curves and would still impress many!
20.11.2025 15:51
👍 0
🔁 0
💬 1
📌 0
These results are unquestionably cool, but that might be the most egregiously misleading y axis I've ever seen. It feels like they are doing everything they can to obfuscate the absolute risk reduction here. When do we ever report cumulative incidence with raw event # on the y axis?
20.11.2025 06:21
👍 0
🔁 0
💬 1
📌 0
Use of a DOAC after a procedure undertaken because you couldn't take a DOAC, to prevent a complication from that procedure
27.10.2025 03:57
👍 0
🔁 0
💬 0
📌 0
🚨 Just published! This guideline provides multi-disciplinary clinical teams with practical recommendations for SGLT2is, MRAs, ARNI and drugs with GLP-1 receptor agonist activity.
Read the guideline here: onlinecjc.ca/article/S082...
#Cardiosky #HeartFailure
20.10.2025 14:00
👍 3
🔁 6
💬 0
📌 0
Not with the AI piece, but I find the device and its app very clunky
16.09.2025 05:39
👍 1
🔁 0
💬 1
📌 0
Comparison of Quadruple Therapy Sequencing Strategies for Heart Failure With Reduced Ejection Fraction | Journal of the American Heart Association
Comparison of Quadruple Therapy Sequencing Strategies for Heart Failure With Reduced Ejection Fraction | Journal of the American Heart Association www.ahajournals.org/doi/10.1161/...
12.09.2025 00:18
👍 2
🔁 3
💬 0
📌 0
And absolute risk reduction
29.08.2025 23:24
👍 0
🔁 0
💬 0
📌 0
DIGIT-HF + DIG pooled
(DIG: composite of all-cause death & HF hospitalization calculated using IPD since this endpoint was not originally reported in the trial manuscript):
29.08.2025 23:22
👍 1
🔁 0
💬 1
📌 0
CR-DECIDE
7/ Next steps include further validation & impact analysis. It could also be used in some clever analyses of RCTs to assess risk-based heterogeneity of treatment effect. Ultimately, this is a tool to inform patients with CAD of their prognosis: decisionaid.ca/cr-decide can be used for this now
14.07.2025 17:03
👍 0
🔁 0
💬 0
📌 0
5/ We developed models with all predictors & "reduced", simpler models with fewer, readily-available variables. Importantly for the health status models, replacing patient-reported QoL with CCS/NYHA class substantially worsened predictions; there's no substitute for eliciting directly from patients!
14.07.2025 17:03
👍 0
🔁 0
💬 1
📌 0
4/ We developed the MACE model in a BC-based registry (n=24,990) & the health status models in the APPROACH registry in AB (n=13,312)🇨🇦. We considered known predictors of MACE & CAD-related health status, including history, labs, & coronary anatomy
14.07.2025 17:03
👍 0
🔁 0
💬 1
📌 0
3/ Unlike with primary CV prevention, there are no widely-used risk calculators in patients with existing CAD to guide decision-making. Everyone with CAD is considered "high risk" with various features used to qualitatively de-risk/up-risk patients.
14.07.2025 17:03
👍 0
🔁 0
💬 1
📌 0
2/ We set out to develop a set of clinical prediction models ("risk calculators") to predict major adverse cardiovascular events (MACE) @3yr & health status @1yr in patients with stable CAD to help facilitate shared decision-making re: revascularization & secondary prevention medications
14.07.2025 17:03
👍 0
🔁 0
💬 1
📌 0
We made a new decision aid! Introducing CR-DECIDE: decisionaid.ca/cr-decide/
A brief 🧵 on how we developed it & how it can be used 1/7
14.07.2025 17:03
👍 1
🔁 0
💬 1
📌 0